SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-05-074065
Filing Date
2005-04-12
Accepted
2005-04-11 17:53:04
Documents
2
Period of Report
2005-05-18
Effectiveness Date
2005-04-12

Document Format Files

Seq Description Document Type Size
1 NOTICE & PROXY STATEMENT ddef14a.htm DEF 14A 196069
2 GRAPHIC g51372img001.jpg GRAPHIC 95183
  Complete submission text file 0001193125-05-074065.txt   292946
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-27570 | Film No.: 05744845
SIC: 8731 Services-Commercial Physical & Biological Research